Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Lovenox superiority established in ESSENCE trial

Aug. 21, 1997

Fibrinogen antagonists from Yamanouchi

Aug. 20, 1997

Stanford announces three studies on leg ischemia treatments

Aug. 20, 1997

Glaxo Wellcome discloses a new series of thrombin inhibitors

Aug. 18, 1997

Arginine mimetics from Boehringer Mannheim

Aug. 13, 1997

Normiflo launched in U.S.

Aug. 12, 1997

Dietary changes may pose threat to patients on oral anticoagulants

Aug. 8, 1997

Texas Biotechnology and SmithKline Beecham form marketing alliance for Novastan

Aug. 7, 1997

Berlex reports novel anticoagulants

Aug. 6, 1997

Barr Laboratories halts shipment of warfarin educational materials

Aug. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...